Evidence map›Paper›PMID 42774339›Full record

ArticleFrontiers in artificial intelligence2026

An interpretable machine learning framework using multi-phase computed tomography for differentiation of adrenal lipid-poor adenomas and pheochromocytomas.

Panliang Zhao, Fangmei Zhu, Cheng Yan, Zongfeng Niu, Linyang He, Zongyu Xie, Jian Wang

Abstract read
In one paragraph

Article in Frontiers in artificial intelligence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Panliang Zhao *Department of Radiology, Tongde Hospital of Zhejiang Province Affiliated to Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Fangmei Zhu *Department of Radiology, Affiliated Hangzhou First People's Hospital, Westlake University School of Medicine, Hangzhou, Zhejiang, China.
Cheng YanDepartment of Radiology, Tongde Hospital of Zhejiang Province Affiliated to Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Zongfeng NiuDepartment of Radiology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Linyang HeJianpei Technology, Hangzhou, Zhejiang, China.
Zongyu XieDepartment of Radiology, The First Affiliated Hospital of Bengbu Medical University, Bengbu, Anhui, China.
Jian WangDepartment of Radiology, Tongde Hospital of Zhejiang Province Affiliated to Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To develop and validate an interpretable machine learning (ML) framework that differentiates adrenal lipid-poor adenomas (LPAs) from pheochromocytomas (PHEOs) using radiomic features derived from multi-phase contrast-enhanced computed tomography (CECT). Methods: This retrospective study included 229 patients with pathologically confirmed adrenal tumours (132 LPAs, 97 PHEOs). Lesions were stratified into washout (absolute percentage washout [APW] > 60%) and non-washout (APW ≤ 60%) cohorts according to established criteria. We trained decision tree (DT), support vector machine (SVM), and logistic regression (LR) models using a predefined set of clinically relevant CT features. The inherently interpretable DT model was further dissected to revealr key discriminative features and its underlying decision logic. Model performance was evaluated using the area under the curve (AUC) with 95% confidence intervals. Results: The DT model achieved excellent diagnostic performance, with an AUC of 0.977 (95% CI: 0.934-1.000) in the washout group and 0.983 (95% CI: 0.962-1.000) in the non-washout group. Feature importance analysis identified cystic degeneration as the most influential discriminator, followed by enhancement potential (EP) and baseline attenuation (CTu). The DT's hierarchical decision rules provided clear and clinically transparent pathways. Conclusion: This interpretable ML framework accurately distinguishes LPAs from PHEOs. The DT model strikes an optimal balance between high diagnostic accuracy and inherent interpretability, offering a practical tool that may enhance clinical confidence when managing indeterminate adrenal lesions.

Indexed as

adrenal glandartificial intelligencecomputed tomographylipid-poor adenomamachine learningpheochromocytoma

Identifiers

PMID42774339
PMCPMC13593809

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.